BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.
Sector:
Distribution Services
Industry:
Wholesale Distributors
Employees:
30
Frequently Asked Questions
What is Market Cap of BioNexus Gene Lab Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. BioNexus Gene Lab Corp market cap is $9.38M.
What is the 52-week high for BioNexus Gene Lab Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioNexus Gene Lab Corp 52 week high is $15.60 as of September 18, 2025.
What is the 52-week low for BioNexus Gene Lab Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioNexus Gene Lab Corp 52 week low is $2.01 as of September 18, 2025.
What is BioNexus Gene Lab Corp stock price today?
BioNexus Gene Lab Corp stock price today is $5.70.
What was BioNexus Gene Lab Corp stock price yesterday?
BioNexus Gene Lab Corp stock price yesterday was $5.22.
What is the PE ratio of BioNexus Gene Lab Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. BioNexus Gene Lab Corp’s P/E ratio is -3.20.
What is the Price-to-Book ratio of BioNexus Gene Lab Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. BioNexus Gene Lab Corp P/B ratio is 1.2468.
What is the 50-day moving average of BioNexus Gene Lab Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BioNexus Gene Lab Corp 50-day moving average is $5.40.
How many employess does BioNexus Gene Lab Corp has?
